Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DNMT3A | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
mRNA | RMND5A | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
mRNA | ZNF302 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | ZNF606 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | MEX3A | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-07 |
mRNA | MBD1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | ZNF260 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | ADNP2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |